Abstract:Objective To evaluate the value of transrectal ultrasound-guided systematic prostate biopsy and magnetic resonance imaging(MRI) suspicious targeted biopsy in the biopsy of prostate cancer.Methods A retrospective analysis was performed in 181 patients with suspected prostate cancer underwent transrectal ultrasound-guided prostate biopsy from September 2011 to September 2013 in the Second Affiliated Hospital of Zhejiang University School of Medicine.In all the 181 patients had the transrectal ultrasound-guided systematic biopsy,116 patients with suspicious MRI had two additional targeted biopsies.Prostate cancers were detected in 97 of 181 patients,and the prostatic hyperplasia were detected in 84 patients.The detection rate of transrectal ultrasound-guided systematic prostate biopsy,suspicious MRI targeted biopsy and combined biopsy in prostate cancer were tested by χ2 test.Compared with pathological results,the sensitivity,specificity,accuracy,positive predictive value and negative predictive value of transrectal ultrasound-guided systematic prostate biopsy and suspicious MRI targeted biopsy were calculated and tested by χ2 test.Results Prostate cancer was detected in 97 of 181 patients(53.6%),63(34.8%) was detected by transrectal ultrasound-guided systematic prostate biopsy,and 81(44.8%) was detected by suspicious MRI targeted biopsy.The suspicious MRI targeted biopsy detected more prostate cancers which there had statistical differences compared with transrectal ultrasound-guided systematic prostate biopsy(χ2=34.830,P=0.015).Transrectal ultrasound guided prostate systematic biopsy missed 34 cases of prostate cancer,and suspicious MRI targeted biopsy missed 16 cases,accounting for 35.1%(34/97) and 16.5%(16/97) of prostate cancer.The 181 patients were biopsied a total of 1 896 cores,including transrectal ultrasound guided systematic biopsy 1 448 cores and suspicious MRI targeted biopsy 448 cores.The sensitivity,specifi city,positive predictive value and negative predictive value of suspicious MRI targeted biopsy was 89.8%(280/312),87.4%(1 384/1 584),58.3%(280/480),97.7%(1 384/1 416) compared with the sensitivity of 71.8%(224/312),specifi city of 22.7%(360/1 584),positive predictive value of 15.5%(224/1 448) and negative predictive value of 80.4%(360/448) in transrectal ultrasound-guided systematic prostate biopsy(χ2=14.008,96.037,143.049,170.729,all P < 0.001).Conclusions The detection rate of prostate cancer of suspicious MRI targeted biopsy is higher than transrectal ultrasound-guided systematic prostate biopsy,but can′t replace transrectal ultrasound-guided systematic prostate biopsy.The two methods are complementary to improve the prostate cancer detection rate.

Significance of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer

The value of transrectal ultrasound-guided systematic prostate biopsy and additional targeted cores from suspicious magnetic resonance imaging in the biopsy of prostate cancer

Evaluation of ultrasound elastography in the diagnosis of prostate cancer

3-D Multi-parametric Contrast-Enhanced Ultrasound for the Prediction of Prostate Cancer.

3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

Diagnostic Value of Contrast - enhanced Ultrasound, Transrectal Real - time Tissue Elastography and Magnetic Resonance Imaging for Prostate Cancer

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Comparison of contrast-enhanced ultrasonography with dynamic contrast material-enhanced magnetic resonance imaging for prostate cancer detection

The Comparative Study on the Application Value of Transperineal Prostate Combined Biopsy and Transrectal Prostate Systematic Biopsy in Diagnosing Prostate Cancer in Patients with Different PSA Zones.

The Clinical Value of Trausrectal Ultrasound Guided Prostate 13-Core Needle Biopsy

A Comparative Study of Transrectal Contrast-Enhanced Ultrasound Assisted Prostate Biopsy and System-Ic Prostate Biopsy

Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results

Contrast-enhanced Transrectal Ultrasound Can Reduce Collection of Unnecessary Biopsies when Diagnosing Prostate Cancer and is Predictive of Biochemical Recurrence Following a Radical Prostatectomy in Patients with Localized Prostate Cancer

The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the gleason score of prostate cancer by a subjective blood flow grading scale

[Diagnostic Value of Lesion-Directed Prostate Biopsy under TRUS in Early Detection of Prostate Cancer].

A comparative evaluation of transrectal versus transperineal prostate biopsy in safety

Clinical utility of freehand TRUS guided transperineal biopsy with" 12 + X"cores

[The Value of Diffusion-Weighted MR Imaging Combined with Transrectal Ultrasound for Transrectal Prostate Biopsy].

Comparison of Value Between Transperineal Template Guided Biopsy and Transrectal Biopsy

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis